← Back to headlines
Jacob Funds Invests in Cabaletta Bio and Prime Medicine
Jacob Funds has established positions in Cabaletta Bio (CABA) and Prime Medicine (PRME), focusing on next-generation gene therapy companies.
18 Feb, 13:34 — 18 Feb, 13:34
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Investment Outlook: Dividend Aristocrats Poised for 2026 Rebound
14m ago
Stock Market Today, Feb. 20: CoreWeave Falls After Blue Owl Data Center Financing Failure Raises Funding Concerns
54m ago
Why CoreWeave Was Plunging To End the Week Today
54m ago
Costco Price Target Raised by Evercore ISI and Citi After Q2 Beat
54m ago